Dr. Shengjie Guo 郭胜杰
Chief Physician
Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery for adrenal tumors, kidney cancer, and complex retroperitoneal tumors. Performs laparoscopic, single-port, and robotic procedures, including nephron-sparing surgery, vena cava tumor thrombectomy, and treatment of retroperitoneal sarcomas.
Dr. Guo holds a medical doctorate and serves as a master’s supervisor. After earning a bachelor’s degree from Wuhan University (2001–2006) and completing graduate studies at the First Affiliated Hospital of Sun Yat-sen University (2006–2011), Dr. Guo was a visiting scholar at the University of Maryland School of Medicine (2009–2010). Dr. Guo has worked in the Department of Urology at Sun Yat-sen University Cancer Center since 2011.
Professional roles
- Vice Chair, First Youth Committee of Urogenital Professional Committee, Guangdong Anti-Cancer Association
- Member, Ninth Youth Committee of Urology Branch, Guangdong Medical Association
Name order: in Chinese the family name comes first (Guo Shengjie). Papers usually list the name as Shengjie Guo or Guo S.
Selected publications
88 papers on PubMed matched by name and affiliation; 15 as first or senior author since 2016. Most recent first- or senior-author papers:
- Eur Radiol, 2026 (senior author): Comparative effectiveness of thermal ablation, radiotherapy, and surgery for adrenal metastases: a multi-institutional cohort study. PubMed 41824040
- Transl Androl Urol, 2026 (senior author): Gasless single-port retroperitoneal laparoscopic adrenalectomy: a novel option for adrenal tumors. PubMed 42164354
- BMC Med Imaging, 2025 (senior author): Differentiating between adrenocortical carcinoma and pheochromocytoma by a CT-based radiomics model: a multicenter retrospective study. PubMed 40750857
- Discov Oncol, 2024 (senior author): Serum hemoglobin and albumin levels serve as prognostic predictors after adrenal metastasectomy. PubMed 39692934
- Cancer Med, 2024 (senior author): Trajectories of squamous cell carcinoma antigen and outcomes of patients with advanced penile cancer after chemotherapy based on paclitaxel, ifosfamid, and cisplatin regimen. PubMed 38888362
- Asian J Surg, 2023 (senior author): Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis. PubMed 37147255
- Front Oncol, 2020 (senior author): Comparison of T2N0M0 and T3aN0M0 in Predicting the Prognosis of Patients With Renal Cell Carcinoma. PubMed 33072592
- Cancer Med, 2020 (senior author): Urachal carcinoma: Impact of recurrence pattern and lymphadenectomy on long-term outcomes. PubMed 32329250
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion